Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

7-Methylguanosine (CAS 20244-86-4)

5.0(1)
Write a reviewAsk a question

See product citations (4)

Alternate Names:
2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methylpurin-9-ium-6-olate
Application:
7-Methylguanosine is a useful nucleotide analog
CAS Number:
20244-86-4
Purity:
≥98%
Molecular Weight:
297.27
Molecular Formula:
C11H15N5O5
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

7-Methylguanosine, often symbolized as m7G, is a modified nucleoside that plays a role in the post-transcriptional modification of RNA, particularly in the context of mRNA capping. This modification occurs at the 5′ end of messenger RNA (mRNA) molecules, where the 7-Methylguanosine cap is added in a 5′ to 5′ triphosphate linkage. This unique cap structure is essential for RNA stability, efficient translation, and protection from exonucleolytic degradation. The capping process is vital for the proper expression of genes, as it facilitates the binding of mRNA to the ribosome, thereby enhancing translational efficiency. Additionally, 7-Methylguanosine capping influences the transport of mRNA from the nucleus to the cytoplasm and plays a role in the recognition and removal of defective mRNA by the quality control mechanisms within the cell. In research, the study of 7-Methylguanosine and its role in mRNA capping has significantly contributed to understanding the molecular mechanisms underlying RNA processing and regulation. This has implications for a wide range of biological processes, including cell growth, differentiation, and response to environmental stimuli.


7-Methylguanosine (CAS 20244-86-4) References

  1. Reversible methylation of m6Am in the 5' cap controls mRNA stability.  |  Mauer, J., et al. 2017. Nature. 541: 371-375. PMID: 28002401
  2. 7-Methylguanosine monophosphate analogues with 5'-(1,2,3-triazoyl) moiety: Synthesis and evaluation as the inhibitors of cNIIIB nucleotidase.  |  Kozarski, M., et al. 2018. Bioorg Med Chem. 26: 191-199. PMID: 29195795
  3. 7-Methylguanosine Modifications in Transfer RNA (tRNA).  |  Tomikawa, C. 2018. Int J Mol Sci. 19: PMID: 30562954
  4. METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation.  |  Pandolfini, L., et al. 2019. Mol Cell. 74: 1278-1290.e9. PMID: 31031083
  5. Highly Regioselective Methylation of Guanosine Nucleotides: An Efficient Synthesis of 7-Methylguanosine Nucleotides.  |  Senthilvelan, A., et al. 2019. Curr Protoc Nucleic Acid Chem. 79: e100. PMID: 31756051
  6. Transcriptome-Wide Detection of Internal N7-Methylguanosine.  |  Zhang, LS., et al. 2021. Methods Mol Biol. 2298: 97-104. PMID: 34085240
  7. Mapping of 7-methylguanosine (m7G), 3-methylcytidine (m3C), dihydrouridine (D) and 5-hydroxycytidine (ho5C) RNA modifications by AlkAniline-Seq.  |  Marchand, V., et al. 2021. Methods Enzymol. 658: 25-47. PMID: 34517949
  8. The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases.  |  Zhou, W., et al. 2022. Crit Rev Clin Lab Sci. 59: 203-218. PMID: 34775884
  9. Synthesis of α-D-Ribose 1-Phosphate and 2-Deoxy-α-D-Ribose 1-Phosphate Via Enzymatic Phosphorolysis of 7-Methylguanosine and 7-Methyldeoxyguanosine.  |  Varizhuk, IV., et al. 2022. Curr Protoc. 2: e347. PMID: 35050551
  10. Characterization of 7-Methylguanosine Identified Biochemical Recurrence and Tumor Immune Microenvironment in Prostate Cancer.  |  Xin, S., et al. 2022. Front Oncol. 12: 900203. PMID: 35677157
  11. Construction and Validation of a Novel Prognostic Signature of Idiopathic Pulmonary Fibrosis by Identifying Subtypes Based on Genes Related to 7-Methylguanosine Modification.  |  Huang, T. and He, WY. 2022. Front Genet. 13: 890530. PMID: 35754799
  12. Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures.  |  Lu, F., et al. 2022. Front Oncol. 12: 876360. PMID: 35785179
  13. Comprehensive analysis of 7-methylguanosine and immune microenvironment characteristics in clear cell renal cell carcinomas.  |  Xiao, Y., et al. 2022. Front Genet. 13: 866819. PMID: 36003341
  14. A novel prognostic 7-methylguanosine signature reflects immune microenvironment and alternative splicing in glioma based on multi-omics analysis.  |  Wang, Z., et al. 2022. Front Cell Dev Biol. 10: 902394. PMID: 36036011
  15. A Novel 7-Methylguanosine (m7G)-Related Gene Signature for Overall Survival Prediction in Patient with Clear Cell Renal Cell Carcinoma.  |  Fu, Y., et al. 2023. J Oncol. 2023: 9645038. PMID: 37089261

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

7-Methylguanosine, 25 mg

sc-221113
25 mg
$57.00

7-Methylguanosine, 100 mg

sc-221113A
100 mg
$125.00